-
1 Comment
Asymchem Laboratories (Tianjin) Co., Ltd is currently in a long term uptrend where the price is trading 17.6% above its 200 day moving average.
From a valuation standpoint, the stock is 156.5% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 24.7.
Asymchem Laboratories (Tianjin) Co., Ltd's total revenue rose by 25.8% to $817M since the same quarter in the previous year.
Its net income has increased by 38.9% to $191M since the same quarter in the previous year.
Finally, its free cash flow fell by 368.6% to $-90M since the same quarter in the previous year.
Based on the above factors, Asymchem Laboratories (Tianjin) Co., Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Biotechnology |
| ISIN | CNE100002BZ6 |
| Market Cap | 34B |
|---|---|
| Beta | 0.3 |
| Target Price | 125.609 |
| Dividend Yield | 1.0% |
| PE Ratio | 33.61 |
Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, and continuous flow; and chemical process R&D, analytical services, regulatory, pre-clinical R&D support, PPQ readiness, and back integration services. It also engages in technology services comprising flow chemistry, biocatalysis, fermentation, chiral synthesis, hazardous reactions, low temperature, highly potent, non-precious metal catalysis (NPMC), high-pressure chemistry, electrochemistry, and photochemistry. In addition, the company offers drug products, such as pharma solutions, preformulation, solid oral dosage, and injectables; and biotech solutions, drug substance and development, and consultation services. The company was founded in 1998 and is headquartered in Tianjin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002821.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
